Segment Information - Segment Revenue, Operating (Loss) Income and Depreciation and Amortization (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting Information [Line Items]
Revenue	$ 30,341	$ 52,483	$ 92,851	$ 104,614
Total operating (loss) income	(5,369)	21,412	(5,032)	7,600
Depreciation and amortization	2,126	2,151	6,555	6,365
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	30,341	52,483	92,851	104,614
Total operating (loss) income	865	24,643	7,423	16,933
Operating Segments [Member] | Medical Device [Member]
Segment Reporting Information [Line Items]
Revenue	23,383	46,014	71,754	84,739
Total operating (loss) income	(2,288)	21,777	(2,210)	7,483
Depreciation and amortization	1,958	1,997	5,928	5,883
Operating Segments [Member] | In Vitro Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue	6,958	6,469	21,097	19,875
Total operating (loss) income	3,153	2,866	9,633	9,450
Depreciation and amortization	92	78	285	230
Corporate Non Segment [Member]
Segment Reporting Information [Line Items]
Total operating (loss) income	(6,234)	(3,231)	(12,455)	(9,333)
Depreciation and amortization	$ 76	$ 76	$ 342	$ 252